Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelaic Acid Gel vs Finacea in Moderate Facial Rosacea
NCT03094403Phase 1Completed
- Start
- Jul 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of azelaic acid 15% gel vehicle in rosacea (3 arms). Primary endpoint: Change in inflammatory lesion counts at 12 weeks. Started Jul 2016; status: completed.
02
Drugs
azelaic acid 15% gel vehicle
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03094403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03094403.